Anavex Life Sciences Corp (AVXL)
3.44
+0.05
(+1.47%)
USD |
NASDAQ |
Apr 26, 14:31
Anavex Life Sciences Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| September 30, 2014 | -0.003M |
| June 30, 2014 | -0.0023M |
| March 31, 2014 | -0.0023M |
| December 31, 2013 | -0.0023M |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
| June 30, 2011 | -0.0033M |
| March 31, 2011 | -0.0033M |
| December 31, 2010 | -0.0033M |
| September 30, 2010 | -0.0033M |
| June 30, 2010 | |
| March 31, 2010 |
| Date | Value |
|---|---|
| December 31, 2009 | |
| September 30, 2009 | |
| June 30, 2009 | |
| March 31, 2009 | |
| December 31, 2008 | |
| September 30, 2008 | -0.0011M |
| June 30, 2008 | -0.1057M |
| March 31, 2008 | -0.0788M |
| December 31, 2007 | 0.00 |
| September 30, 2007 | 0.00 |
| June 30, 2007 | 0.00 |
| March 31, 2007 | 0.00 |
| December 31, 2006 | 0.00 |
| September 30, 2006 | 0.00 |
| June 30, 2006 | 0.00 |
| March 31, 2006 | 0.00 |
| December 31, 2005 | 0.00 |
| September 30, 2005 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Ventyx Biosciences Inc | 100.94M |
| Checkpoint Therapeutics Inc | -- |
| Vertex Pharmaceuticals Inc | -3.142B |
| Sarepta Therapeutics Inc | -165.80M |
| NovaBay Pharmaceuticals Inc | -0.019M |